Literature DB >> 18291366

Focus on molecules: Transforming growth factor beta induced protein (TGFBIp).

Kasper Runager1, Jan J Enghild, Gordon K Klintworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18291366      PMCID： PMC2577226          DOI： 10.1016/j.exer.2007.12.001

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  4 in total

1.  Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas.

Authors:  Rolf B Andersen; Henrik Karring; Torben Møller-Pedersen; Zuzana Valnickova; Ida B Thøgersen; Chris J Hedegaard; Torsten Kristensen; Gordon K Klintworth; Jan J Enghild
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

2.  Kerato-epithelin mutations in four 5q31-linked corneal dystrophies.

Authors:  F L Munier; E Korvatska; A Djemaï; D Le Paslier; L Zografos; G Pescia; D F Schorderet
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

3.  cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta.

Authors:  J Skonier; M Neubauer; L Madisen; K Bennett; G D Plowman; A F Purchio
Journal:  DNA Cell Biol       Date:  1992-09       Impact factor: 3.311

4.  A model of FAS1 domain 4 of the corneal protein beta(ig)-h3 gives a clearer view on corneal dystrophies.

Authors:  Naomi J Clout; Erhard Hohenester
Journal:  Mol Vis       Date:  2003-09-11       Impact factor: 2.367
  4 in total
  22 in total

1.  Hydrogen exchange mass spectrometry as an analytical tool for the analysis of amyloid fibrillogenesis.

Authors:  Carsten Scavenius; Shirin Ghodke; Daniel E Otzen; Jan J Enghild
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

Review 2.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

3.  Transforming growth factor β induced mutation-associated phenotype in a Chinese family exhibiting lattice corneal dystrophy.

Authors:  Chao Qu; Man Yu; Xiaoxin Guo; Jing Li; Xiaoqi Liu; Yi Shi; Bo Gong
Journal:  Biomed Rep       Date:  2017-08-30

Review 4.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

5.  Unique TGFBI protein in lattice corneal dystrophy.

Authors:  Yu-Ping Han; Austin J Sim; Smita C Vora; Andrew J W Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

6.  A unique TGFBI protein in granular corneal dystrophy types 1 and 2.

Authors:  Yu-Ping Han; Austin J Sim; Smita C Vora; Andrew J W Huang
Journal:  Curr Eye Res       Date:  2012-06-29       Impact factor: 2.424

7.  NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in Fuchs endothelial corneal dystrophy.

Authors:  Kishore Reddy Katikireddy; Tomas L White; Taiga Miyajima; Shivakumar Vasanth; Duna Raoof; Yuming Chen; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  Free Radic Biol Med       Date:  2017-12-30       Impact factor: 7.376

Review 8.  Fuchs endothelial corneal dystrophy.

Authors:  Hussain Elhalis; Behrooz Azizi; Ula V Jurkunas
Journal:  Ocul Surf       Date:  2010-10       Impact factor: 5.033

9.  Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging.

Authors:  Henrik Karring; Kasper Runager; Zuzana Valnickova; Ida B Thøgersen; Torben Møller-Pedersen; Gordon K Klintworth; Jan J Enghild
Journal:  Exp Eye Res       Date:  2009-09-26       Impact factor: 3.467

10.  Proteomic profiling of TGFBI-null mouse corneas reveals only minor changes in matrix composition supportive of TGFBI knockdown as therapy against TGFBI-linked corneal dystrophies.

Authors:  Ebbe Toftgaard Poulsen; Kasper Runager; Nadia Sukusu Nielsen; Marie V Lukassen; Karen Thomsen; Paige Snider; Olga Simmons; Henrik Vorum; Simon J Conway; Jan J Enghild
Journal:  FEBS J       Date:  2017-11-23       Impact factor: 5.542
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.